Content related to New Research From the Neurological Institute Team

The trial is studying a potential treatment for Dup15q and incorporates an EEG biomarker established by CHLA researchers.

A Children’s Hospital Los Angeles expert shares the latest on tuberous sclerosis complex care and research.

A neuroimmunologist at Children’s Hospital Los Angeles led an effort to create an ICD-10 code for MOGAD—helping to speed access to critical medications.

New immunotherapy treatment is bringing hope to families devastated by DSRD.

Jonathan Santoro, MD, is pioneering a novel treatment—and the first clinical trial— for Down syndrome regression disorder, a devastating condition in young people with Down syndrome.

Dr. Shafali Jeste at Children’s Hospital Los Angeles is seeking biomarkers that can address the incredible variability of autism, an important step toward developing targeted treatments.

A Children’s Hospital Los Angeles team developed the test, which is the first to precisely measure how much cerebrospinal fluid is flowing through a shunt.

A CHLA study finds that racial and socioeconomic disparities contribute to delayed care and treatment for babies with craniosynostosis.